AKAP13 and posterior cortical atrophy: At the same time, by analyzing the survival data of patients, we found that AKAP13 negative patients had shorter overall survival time (Figure 7B), which suggested that AKAP13 expression is negatively correlated with PCa malignant degree and could be used as a potential clinical prognostic indicator.